Behavioral Interventions for In-Treatment Injection Drug Users

  • Laurie Roehrich
  • Tamara L. Wall
  • James L. Sorensen
Part of the AIDS Prevention and Mental Health book series (APMH)


An estimated one million individuals in the United States inject drugs (Institute for Health Policy Studies, 1990). Injecting drug users (IDUs) represent the second largest group at risk for human immunodeficiency virus (HIV) infection, and are the primary source for heterosexual and perinatal HIV transmission (Centers for Disease Control, 1991). Drug injection is more highly concentrated among poor and socially marginal groups. Rates of HIV infection among IDUs vary according to geographical location and generally range from 0% to about 20% (Centers for Disease Control, 1991). In areas such as New York City and Newark, New Jersey, however, over 50% of all IDUs may have been infected (Caussy et al., 1990; Lee et al., 1990). Therefore, the reduction of high-risk behavior is a critical issue in the drug treatment field.


Human Immunodeficiency Virus Drug User Drug Abuse Treatment Injection Drug User Methadone Maintenance Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abdul-Quader, A. S., Friedman, S. R., Des Jarlais, D., Marmor, M. M., Maslansky, R., & Bartelme, S. (1987). Methadone maintenance and behavior by intravenous drug users that can transmit HIV. Contemporary Drug Problems, 14, 425–434.Google Scholar
  2. American Psychological Association. (1991). Special Issue: Homelessness. American Psychologist, 46, 1108–1245.CrossRefGoogle Scholar
  3. Andersen, B. L. (1992). Psychological interventions for cancer patients to enhance the quality of life. Journal of Consulting & Clinical Psychology, 60, 552–568.CrossRefGoogle Scholar
  4. Amodio-Groton, M., & Currier, J. (1992). HIV drug interactions. AIDS Clinical Care, 4, 25–29.CrossRefGoogle Scholar
  5. Barthwell, A., Senay, E., Marks, R., & White, R. (1989). Patients successfully maintained with methadone escaped human immunodeficiency virus infection (letter). Archives of General Psychiatry, 46, 957.PubMedCrossRefGoogle Scholar
  6. Batki, S. L. (1986). Drug abuse, psychiatric disorders, and AIDS: Dual and triple diagnosis. The Western Journal of Medicine, 152, 547–552.Google Scholar
  7. Batki, S. L. (1990). Substance abuse and AIDS: The need for mental health services. In S. M. Goldfinger (Ed.), Psychiatric aspects of AIDS and HIV infection (pp. 55–82). San Francisco: Jossey-Bass Inc.Google Scholar
  8. Batki, S. L., London, J., Goosby, E., Clement, M., Wolfe, R., Ryan, G, French, D., Young, M., Miller, D., Christmas, R., & Sorensen, J. L. (1990, June). Medical care for intravenous drug users with AIDS and ARC: Delivering services at a methadone treatment program. Paper presented at the 6th International Conference on AIDS, San Francisco, CA.Google Scholar
  9. Batki, S. L., Sorensen, J. L., Gibson, D. R., & Maude-Griffin, P. (1990). HIV-infected IV drug users in methadone treatment: Outcome and psychological correlates—a preliminary report. In L. S. Harris (Ed.), Problems of drug dependence, 1989 (DHHS Publication No. ADM 90-1663, pp. 405–406). Rockville, MD: NIDA.Google Scholar
  10. Bliz, O., & Grondbladh, L. (1988, June). AIDS and IV heroin addicts: The preventive effect of methadone maintenance in Sweden. Paper presented at the 4th International Conference on AIDS, Stockholm, Sweden.Google Scholar
  11. Boccellari, A. (1991, May). Care at home for people with dementing illness: Practical suggestions that can make a difference. Bulletin of Experimental Treatments for AIDS, 13-21.Google Scholar
  12. Broers, B., Hirschel, B., Gabriel, V., & Morabia A. (1992, July). Compliance of drug users with Zidovudine treatment. Poster presented at the 7th International Conference on AIDS, Amsterdam, The Netherlands.Google Scholar
  13. Calsyn, D. A., Saxon, A. J., Freeman, G., Jr., & Whittaker, S. (1992). Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. American Journal of Public Health, 82, 573–574.PubMedCrossRefGoogle Scholar
  14. Casadonte, P. P., Des Jarlais, D. C., Friedman, S. R., & Rostrosen, J. P. (1990). Psychological and behavioral impact among intravenous drug users of learning HIV test results. International Journal of the Addictions, 25, 409–426.PubMedGoogle Scholar
  15. Caussy, D., Weiss, S., Blattner, W., French, J., Cantor, E., Ginzberg, H., Altman, R., & Goedert, J. (1990). Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs. AIDS Research & Human Retroviruses, 6, 1459–1467.CrossRefGoogle Scholar
  16. Centers for Disease Control and Prevention. (1986). Additional recommendations to reduce sexual and drug abuse-related transmission of human T-Lymphatropic Virus Type III/lymphoadenopathy-associated virus. Morbidity & Mortality Weekly Report, 35, 152–155.Google Scholar
  17. Centers for Disease Control and Prevention. (1987). Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. Morbidity and Mortality Weekly Report, 36, 509–515.Google Scholar
  18. Centers for Disease Control and Prevention. (1991, July). HIV/AIDS surveillance report. Atlanta, GA: Author.Google Scholar
  19. Childress, A. R., McLellan, A. T., Woody, G. E., & O’Brien, C. P. (1991). Are there minimum conditions necessary to reduce intravenous drug use and AIDS risk behaviors? In R. W. Pickens, C. G. Leukefeld, & C. R. Schuster (Eds.), Improving drug abuse treatment (pp. 167–177). Rockville, MD: U.S. Department of Health & Human Services, NIDA.Google Scholar
  20. Corrigan, S. A., Thompson, K. E., Malow, R. M., & Sorensen, J. L. (1992). A psychoeducational approach to prevent HIV transmission among injection drug users. Psychology of Addictive Behavior, 6, 114–119.CrossRefGoogle Scholar
  21. Dengelegi, L., Weber, J., & Torquato, S. (1990). Drug users’ AIDS-related knowledge, attitudes, and behaviors before and after AIDS education sessions. Public Health Reports, 105, 504–510.PubMedGoogle Scholar
  22. El-Bassel, N., & Schilling, R. F. (1992). 15 month follow-up of women methadone patients taught skills to reduce heterosexual HIV transmission. Public Health Reports, 107, 500–504.PubMedGoogle Scholar
  23. Eraker, S. A., Kirscht, J., & Becker, M. H. (1984). Understanding and improving patient compliance. Annals of Internal Medicine, 100, 258–268.PubMedCrossRefGoogle Scholar
  24. Farley, T. A., Cartter, M. L., Wassell, J. T., & Hadler, J. L. (1992). Predictors of outcome in methadone programs: Effect of HIV counseling and testing. AIDS, 6, 115–121.PubMedCrossRefGoogle Scholar
  25. Feucht, T. E., Stephens, R. C., & Gibbs, B. H. (1991). Knowledge about AIDS among intravenous drug users: An evaluation of an education program. AIDS Education & Prevention, 3, 10–20.Google Scholar
  26. Fischl, M. A. (1991, April). Adherence in the safety and efficacy study of Zidovudine in the treatment of subjects with mildly symptomatic HIV. Paper presented at the Conference of Adherence in AIDS Clinical Trials, San Francisco, California.Google Scholar
  27. Fischl, M. A., Parker, C. B., Pettinelli, C., Wulfsohn, M., Hirsch, M. S., Collier, A. C., Antoniskis, D., Ho, M., Richman, D. D., Fuchs, E., Merigan, T. C., Reichman, R. C., Gold, J., Steigbigel, N., Leoung, G. S., Rasheed, S., Anastasios, T., & the AIDS Clinical Trials Group. (1991). A randomized controlled trial of a reduced daily dose of Zidovudine in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine, 323, 1009–1014.CrossRefGoogle Scholar
  28. Gibson, D. R., Lovelle-Drache, J., Young, M., & Chesney, M. (1992, July). HIV risk linked to psychopathology in IV drug users. Paper presented at the 8th International Conference on AIDS, Amsterdam, the Netherlands.Google Scholar
  29. Gibson, D. R., Young, M., & Lovelle-Drache, J. (1992). Effects of standard versus enhanced antibody test notification on the HIV risk behavior of injection drug users. Unpublished data, University of California, San Francisco, Department of Psychiatry and the Center for AIDS Prevention, San Francisco, CA.Google Scholar
  30. Grimm, M. G., Wolf, B., Bornemann, R., & Bschor, F. (1989). Prevention of HIV infection in parenteral drug abusers: About evaluation and efficacy of opiate-substitution treatment. Paper presented at the 5th International Conference on AIDS, Montreal, Canada.Google Scholar
  31. Hartel, D., Selwyn, P. A., Schoenbaum, E. E., Klein, R. S., & Friedland, G. H. (1988, June). Methadone maintenance treatment and reduced risk of AIDS and AIDS-specific mortality in intravenous drug users. Presented at the 4th International Conference on AIDS, Stockholm, Sweden.Google Scholar
  32. Hayden, C. H., Jereb, J., Dooley, S., Stern, H., & Seawright, M. (1991, June). HIV-related tuberculosis prevention in drug treatment centers and correctional facilities. Paper presented at the 7th International Conference on AIDS, Florence, Italy.Google Scholar
  33. Institute for Health Policy Studies (1990, February). The HIV epidemic: New and continuing challenges for the public and private sectors. Paper prepared for Funders Concerned about AIDS and the Council on Foundations, University of California, San Francisco.Google Scholar
  34. Jacobsen, P. B., Perry, S. W., & Hirsch, D. (1990). Behavioral and psychological responses to HIV antibody testing. Journal of Consulting and Clinical Psychology, 58, 31–37.PubMedCrossRefGoogle Scholar
  35. Lee, H., Weiss, S., Brown, L., Mildvan, D., Shorty, T., Saravolatz, L., Chu, A., Ginzberg, H., Markowitz, N., & Des Jarlais, D. C. (1990). Patterns of HIV-1 and HTLV-I/II in intravenous drug users from the middle atlantic and central region of the USA. Journal of Infectious Diseases, 162, 347–352.PubMedCrossRefGoogle Scholar
  36. London, J., Sorensen, J. L., Roehrich, L., Stall, R., & Delucchi, K. (1992). AIDS-related bereavement among IDUs in methadone maintenance. Unpublished data, University of California, San Francisco.Google Scholar
  37. Lorion, R., & Feiner, R. D. (1986). Research on psychotherapy with the disadvantaged. In S. L. Garfield & A. E. Bergin (Eds.), Handbook of psychotherapy and behavior change (3rd ed., pp. 739–776). New York: John Wiley & Sons.Google Scholar
  38. Magura, S., Grossman, J., Lipton, D. S., Amann, K. R., Koger, J., & Gehan, K. (1989). Correlates of participation in AIDS education and HIV antibody testing by methadone patients. Public Health Reports, 104, 231–240.PubMedGoogle Scholar
  39. Magura, S., Shapiro, J. L., Grossman, J., Lipton, D. S. (1989). Education/support groups for AIDS prevention with at-risk clients. Social Casework, 10-20.Google Scholar
  40. Markowitz, J. G, Klerman, G. L., & Perry, S. W. (1992). Interpersonal psychotherapy of depressed HIV-positive outpatients. Hospital & Community Psychiatry, 43, 885–890.Google Scholar
  41. Marlatt, G. A., & Gordon, J. R. (1985). Relapse prevention. New York: Guilford.Google Scholar
  42. McCusker, J., Stoddard, A., Zapka, J., Morrison, C., Zorn, M., & Lewis, B. (1992). AIDS education for drug abusers: Evaluation of short-term effectiveness. American Journal of Public Health, 82, 533–540.PubMedCrossRefGoogle Scholar
  43. McKusick, L., & Hilliard, R. (1991, June). Multiple loss accounts for worsening distress in a community heavily hit by AIDS. Paper presented at the 7th International Conference on AIDS, Florence, Italy.Google Scholar
  44. Metzger, D. (1992). Risk for AIDS behaviors. Unpublished manuscript, University of Pennsylvania and Philadelphia VAMC, Center for Studies on Addiction, Philadelphia, PA.Google Scholar
  45. Musto, D. (1987). The American disease: Origins of narcotic control. New York: Oxford University Press.Google Scholar
  46. Musto, D. (July, 1991). Opium, cocaine, and marijuana in American history. Scientific American, 40-47.Google Scholar
  47. Novick, D. M., Joseph, H., Croxson, T. S., Salsitz, E. E., Wang, G., & Richman, B. L. (1989, June). Absence of antibody to HIV in long-term, socially rehabilitated methadone maintenance patients. Poster presented at the 5th International Conference on AIDS, Montreal, Canada.Google Scholar
  48. Oppenheimer, G. M. (1991). To build a bridge: The use of foreign models by domestic critics of U. S. drug policy. Milbank Quarterly, 69, 495–526.PubMedCrossRefGoogle Scholar
  49. Ostrow, D. G., Grant, I., & Atkinson, H. (1988). Assessment and management of the AIDS patient with neuropsychiatric disturbances. Journal of Clinical Psychiatry, 49, 14–22.PubMedGoogle Scholar
  50. Ostrow, D. G., Joseph, J. G., Kessler, R., Soucy, J., Tal, M., Eler, M., Chmiel, J., & Phair, J. P. (1989). Disclosure of HIV antibody status: Behavioral and mental health characteristics. AIDS Education and Prevention, 1, 1–11.PubMedGoogle Scholar
  51. Perry, S. W., Jacobsberg, L. B., Fishman, B., Weiler, P. H., Gold, J. W., & Frances, A. J. (1990). Psychological responses to serological testing for HIV. AIDS, 4, 145–152.PubMedCrossRefGoogle Scholar
  52. Price, R. H., Burke, A. C., D’Aunno, T. A., Klingel, D. M., McCaughrin, W. C., Rafferty, J. A., & Vaughn, T. E. (1991). Outpatient drug abuse treatment services, 1988: Results of a national survey. In R. Pickens, C. Leukefeld, & C. Schuster (Eds.) Improving drug abuse treatment (pp. 63–92) (DHHS Publication No. ADM 91-1754). Rockville, MD: NIDA.Google Scholar
  53. Public Health Service. (1988). Report of the Second Public Health Service AIDS Prevention and Control Conference. Public Health Representative, 193, 66–77.Google Scholar
  54. Rappaport, J., Seidman, E., & Davidson, W. S. (1979). Demonstration research and manifest versus true adoption: The natural history of a research project designed to divert adolescents from the legal system. In R. F. Munoz, L. R. Snowden, & J. G. Kelly (Eds.), Social and psychological research in community settings: Designing and conducting programs for social and personal well-being (pp. 101–144). San Francisco: Jossey-Bass, Inc.Google Scholar
  55. Russell, S. (1993, January 7). S. F. reaching bitter AIDS milestone. San Francisco Chronicle, pp. A1, A8.Google Scholar
  56. Samet, J. H., Libman, H., Steger, K. A., Dhawan, R. K., Chen, J., Shevitz, A. H., Dewees-Dunk, R., Levenson, S., Kufe, D., Craven, D. E. (1992). Compliance with Zidovudine therapy in patients infected with human immunodeficiency virus, type I: A cross-sectional study in a municipal hospital clinic. The American Journal of Medicine, 92, 495–502.PubMedCrossRefGoogle Scholar
  57. Selwyn, P. A., Feingold, A. R., Iezza, A., Satyadeo, M., Colley, J., Torres, R., & Shaw, J. F. M. (1989). Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program. Annals of Internal Medicine, 110, 761–763.CrossRefGoogle Scholar
  58. Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989). A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New England Journal of Medicine, 320, 545–550.PubMedCrossRefGoogle Scholar
  59. Sibthorpe, B., Fleming, D., Tesselaar, H., & Gould, J. (1991). Needle use and sexual practices—Differences in perception of personal risk of HIV among intravenous drug users. Journal of Drug Issues, 21, 699–712.Google Scholar
  60. Sisk, J. E., Hatziandreu, E. J., & Hughes, R. (September, 1990). The effectiveness of drug abuse treatment: Implications for controlling AIDS/HIV infection (OTA background paper #6), p. 9.Google Scholar
  61. Sorensen, J. L. (1991). Preventing HIV transmission in drug treatment programs: What works? Journal of Addictive Diseases, 10, 67–79.PubMedCrossRefGoogle Scholar
  62. Sorensen, J. L., Costantini, M. F., & London, J. A. (1989). Coping with AIDS: Strategies for patients and staff in drug abuse treatment programs. Journal of Psychoactive Drugs, 21, 435–440.PubMedCrossRefGoogle Scholar
  63. Sorensen, J. L., Heitzmann, C., & Guydish, J. (1990). Community psychology, drug use, and AIDS. Journal of Community Psychology, 18, 347–353.CrossRefGoogle Scholar
  64. Sorensen, J. L., London, J., Heitzmann, C., Gibson, D. R., Morales, E. S., Dumontet, R., & Acree, M. (In press). Psychoeducational group approach: HIV risk reduction in drug users. AIDS Education & Prevention.Google Scholar
  65. Sorensen, J. L., & Wall, T. L. (1992). Substance abuse and AIDS: Assessment and treatment issues. In L. Vandercreek, S. Knapp, & T. L. Jackson (Eds.), Innovations in clinical practice: A source book (Vol. 11, pp. 541–552). Sarasota, FL: Professional Resource Press.Google Scholar
  66. Stimson, G. V., & Lart, R. (1991). HIV, drugs, and public health in England: New worlds, old tunes. International Journal of the Addictions, 26, 1263–1267.PubMedGoogle Scholar
  67. Stitzer, M. L., Iguchi, M. Y., & Felch, L. (1992). Contingent take-home incentive: Effects on drug use of methadone maintenance patients. Journal of Consulting & Clinical Psychology, 60, 927–934.CrossRefGoogle Scholar
  68. Tannahill, R. (1989). Sex and history. London: Cardinal Press.Google Scholar
  69. Tidone, L., Sileo, F., Goglio, A., & Borra, G. C. (1987). AIDS in Italy. American Journal of Drug and Alcohol Abuse, 13, 485–486.PubMedCrossRefGoogle Scholar
  70. Turner, C. F., Miller, H. G., & Moses, L. E. (Eds.). (1989). AIDS sexual behavior and intravenous drug use. Washington, DC: National Academy Press.Google Scholar
  71. Umbricht-Schneiter, A., Ginn, D. H., Pabst, K. M., & Bigelow, G. E. (1992, June). Providing medical care to patients on methadone: A controlled study of referral versus on-site care. Poster presented at the College on Problems of Drug Dependence, Keystone, Colorado.Google Scholar
  72. Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Jr., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Murphy, R. L., Hardy, W. D., Soeiro, R., Fischl, M. A., Bartlett, J. G., Merigan, T. C., Hysop, N. E., Richman, D. D., Valentine, F. T., Corey, L., & the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. (1990). Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CDC4-positive cells per cubic millimeter. New England Journal of Medicine, 322, 941–949.PubMedCrossRefGoogle Scholar
  73. Watters, J. K., & Cheng, Y. (1991). Toward comprehensive studies of HIV in intravenous drug users: Issues in treatment-based and street-based samples. In P. Hartsock & S. G. Genser, (Eds.), Longitudinal studies of HIV infection in intravenous drug users: Methodological issues in natural history research (DHHS Publication No. ADM 91-1786, pp. 63–74). Rockville, MD: NIDA.Google Scholar
  74. Wermuth, L., Ham, J., & Robbins, L. (1991). Women don’t wear condoms: AIDS risk among sexual partners of IV drug users. In J. Huber & B. E. Schneider, (Eds.), Social relations and the AIDS crisis. Newbury Park, CA: Sage.Google Scholar
  75. Williams, A., Vranizan, D., Goiter, R., Brodie, B., Meakin, R., & Moss, A. (1990, June). Methadone maintenance, HIV serostatus and race in injection drug users (IDU) in San Francisco, CA. Poster presented at the 6th International Conference on AIDS, San Francisco, CA.Google Scholar
  76. Woody, G. E., Luborsky, L., McLellan, A. T., O’Brien, C. P., Beck, A. T., Blaine, J., Herman, I., & Hole, A. (1983). Psychotherapy for opiate addicts. Archives of General Psychiatry, 40, 639–645.PubMedCrossRefGoogle Scholar
  77. Woody, G. E., McLellan, A. T., O’Brien, C. P., & Luborsky, L. (1991). Addressing psychiatric comorbidity. In R. Pickens, C. Leukefeld, & C. Schuster (Eds.) Improving drug abuse treatment (pp. 152–166) (DHHS Publication No. ADM 91-1754). Rockville, MD: NIDA.Google Scholar
  78. Woody, G. E., O’Brien, C. P., McLellan, A. T., Marcovici, M., & Evans, B. D. (1982). The use of antidepressants with methadone in depressed maintenance patients. Annals of the New York Academy of Science, 398, 120–127.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Laurie Roehrich
    • 1
    • 2
  • Tamara L. Wall
    • 1
    • 2
  • James L. Sorensen
    • 1
    • 2
  1. 1.Department of PsychiatryUniversity of CaliforniaSan FranciscoUSA
  2. 2.Substance Abuse ServicesSan Francisco General HospitalSan FranciscoUSA

Personalised recommendations